Evaluation of the Efficacy and Safety of LevoCept

PHASE2CompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 17, 2018

Study Completion Date

November 12, 2020

Conditions
Contraception
Interventions
DRUG

LevoCept

placement of LevoCept IUD

Trial Locations (16)

10032

Columbia University Medical Center, New York

19104

Hospital of the University of Pennsylvania, Philadelphia

19114

Clinical Research of Philadelphia, LLC, Philadelphia

30322

Emory University School of Medicine Gynecology/Obstetrics, Atlanta

33161

Healthcare Clinical Data, Inc., North Miami

43209

Ohio State University, Columbus

45267

University of Cincinnati Physicians Company, Inc, Cincinnati

78414

Advanced Research Associates, Corpus Christi

80045

University Of Colorado Department of Obstetrics & Gyncology, Aurora

84132

University of Utah Healthcare Health Sciences Center, Salt Lake City

90010

Essential Access Health-Los Angeles, Los Angeles

94710

Essential Access Health-Berkeley, Berkeley

95817

University of California Davis Health System Department of Obstetrics and Gynecology, Sacramento

96826

Kapiolani Medical Center for Women and Children, Honolulu

97239

Oregon Health & Science University, Portland

98105

Seattle Women's: Health, Research, Gynecology, Seattle

All Listed Sponsors
collaborator

Synteract, Inc.

INDUSTRY

lead

Sebela Women's Health Inc.

INDUSTRY

NCT02882191 - Evaluation of the Efficacy and Safety of LevoCept | Biotech Hunter | Biotech Hunter